Home

Zenotech Laboratories Ltd EPS

Image

Zenotech Laboratories Ltd

NSE: ZENOTECHLAB

EPS

₹ 0.75

Last updated on: May 23, 2025

Key Highlights

  • The Earning per Share of Zenotech Laboratories Ltd is ₹ 0.75 as of 23 May 25 .
  • The earning per share of Zenotech Laboratories Ltd changed from ₹ 0.24 to ₹ 0.2 over 8 quarters. This represents a CAGR of -8.71% .

Historical Earning per Share of Zenotech Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Zenotech Laboratories Ltd

Market Cap

377 Cr

EPS

0.8

P/E Ratio (TTM)

82.4

P/B Ratio (TTM)

3.9

Day’s High

64.99

Day’s Low

61.65

DTE

0.0

ROE

4.8

52 Week High

107.79

52 Week Low

51.0

ROCE

9.0

Market Price of Zenotech Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Zenotech Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
23 May 202561.82
22 May 202563.47
21 May 202563.33
20 May 202563.13
19 May 202564.47
16 May 202560.73
15 May 202559.33
14 May 202557.02
13 May 202556.84
12 May 202556.03

SWOT Analysis Of Zenotech Laboratories Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Zenotech Laboratories Ltd

Asset Value vs Market Value of Zenotech Laboratories Ltd

Market Value

377

Asset Value

Value addition

8.1 X

42

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Zenotech Laboratories Ltd377.29
Sun Pharmaceutical Industries Ltd403868
Divis Laboratories Ltd172042
Cipla Ltd119898
Torrent Pharmaceuticals Ltd107387
Dr Reddys Laboratories Ltd102617

Historical Market Cap of Zenotech Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Zenotech Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Zenotech Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Zenotech Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Zenotech Laboratories Ltd News Hub

Zenotech Laboratories schedules AGM

Zenotech Laboratories announced that the 35th Annual General Meeting (AGM) of the company will be he

Read more

31 Aug 24

Zenotech Laboratories to discuss results

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 23 October 202

Read more

18 Oct 24

Zenotech Laboratories standalone net profit declines 52.30% in the September 2024 quarter

Net profit of Zenotech Laboratories declined 52.30% to Rs 1.35 crore in the quarter ended September

Read more

23 Oct 24

Zenotech Laboratories schedules board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 28 January 202

Read more

20 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Zenotech Laboratories Ltd

What is the EPS of Zenotech Laboratories Ltd stock?

The Earnings Per Share (EPS) of Zenotech Laboratories Ltd is 0.75. An EPS is the amount of net income attributed to each share of a common stock.

How is Zenotech Laboratories Ltd EPS calculated?

The EPS of Zenotech Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Zenotech Laboratories Ltd report its EPS?

Zenotech Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Zenotech Laboratories Ltd EPS?

Factors that influence the EPS of Zenotech Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Zenotech Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Zenotech Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions